337 related articles for article (PubMed ID: 18825588)
1. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Nishikawa J; Kudo T; Sakata S; Benno Y; Sugiyama T
Scand J Gastroenterol; 2009; 44(2):180-6. PubMed ID: 18825588
[TBL] [Abstract][Full Text] [Related]
2. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
Nomura T; Ohkusa T; Okayasu I; Yoshida T; Sakamoto M; Hayashi H; Benno Y; Hirai S; Hojo M; Kobayashi O; Terai T; Miwa H; Takei Y; Ogihara T; Sato N
Aliment Pharmacol Ther; 2005 Apr; 21(8):1017-27. PubMed ID: 15813838
[TBL] [Abstract][Full Text] [Related]
4. Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene.
Harada A; Ohkusa T; Kushima K; Sakamoto M; Benno Y; Beppu K; Shibuya T; Sakamoto N; Watanabe S
Scand J Gastroenterol; 2008; 43(4):423-30. PubMed ID: 18365907
[TBL] [Abstract][Full Text] [Related]
5. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
Uehara T; Kato K; Ohkusa T; Sugitani M; Ishii Y; Nemoto N; Moriyama M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S62-6. PubMed ID: 20586868
[TBL] [Abstract][Full Text] [Related]
7. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.
Stanislawowski M; Wierzbicki PM; Golab A; Adrych K; Kartanowicz D; Wypych J; Godlewski J; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():71-5. PubMed ID: 20083854
[TBL] [Abstract][Full Text] [Related]
8. Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy.
Sato K; Chiba T; Ohkusa T
Hepatogastroenterology; 2009; 56(93):1016-21. PubMed ID: 19760932
[TBL] [Abstract][Full Text] [Related]
9. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.
Macfarlane S; Furrie E; Cummings JH; Macfarlane GT
Clin Infect Dis; 2004 Jun; 38(12):1690-9. PubMed ID: 15227614
[TBL] [Abstract][Full Text] [Related]
10. Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.
Koido S; Ohkusa T; Kajiura T; Shinozaki J; Suzuki M; Saito K; Takakura K; Tsukinaga S; Odahara S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
PLoS One; 2014; 9(1):e86702. PubMed ID: 24489770
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.
Ohkusa T; Nomura T; Terai T; Miwa H; Kobayashi O; Hojo M; Takei Y; Ogihara T; Hirai S; Okayasu I; Sato N
Scand J Gastroenterol; 2005 Nov; 40(11):1334-42. PubMed ID: 16334443
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy.
Tsuda Y; Yoshimatsu Y; Aoki H; Nakamura K; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
Scand J Gastroenterol; 2007 Nov; 42(11):1306-11. PubMed ID: 17852859
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population.
Chen CC; Isomoto H; Narumi Y; Sato K; Oishi Y; Kobayashi T; Yanagihara K; Mizuta Y; Kohno S; Tsukamoto K
Clin Immunol; 2008 Feb; 126(2):165-71. PubMed ID: 17980669
[TBL] [Abstract][Full Text] [Related]
15. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease.
Sipponen T; Turunen U; Lautenschlager I; Nieminen U; Arola J; Halme L
Scand J Gastroenterol; 2011 Nov; 46(11):1324-33. PubMed ID: 21879802
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
[TBL] [Abstract][Full Text] [Related]
20. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission.
Martinez C; Antolin M; Santos J; Torrejon A; Casellas F; Borruel N; Guarner F; Malagelada JR
Am J Gastroenterol; 2008 Mar; 103(3):643-8. PubMed ID: 18341488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
